Delivery Order SPE2DB24D1034-SPE2DB24FVZN0

Award Date 4/29/24
Potential Completion Date 4/30/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The 12-month, firm fixed price contract, valued at $5,886.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office division. The contract has a total ceiling value of $4,877.12 and is a firm fixed-price delivery order, with an ultimate completion date of June 4, 2024. The contract was awarded on June 3, 2024, and there...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 MCG inhalers. The $12,577.37 contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $2,605.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support...
This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,612.51 and an ultimate completion date of April 29, 2024. It is a firm fixed-price delivery order contract, awarded on April 26, 2024, without any set-aside designation. Amerisourcebergen...
This federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $10,470.61 and is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves...
This federal contract award is a firm fixed price delivery order for an Advair HFA 115-21 MCG inhaler valued at $3,553.17, issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a performance period through February 21, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the sole awardee on an indefinite delivery contract (IDC) with DLA valued up to...
This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the U.S. government. The contract, valued at $5,788.21, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
This federal contract award is for the delivery of Advair HFA 115-21 mcg inhalers to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor, AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $7,158.70 and a performance period through March 27, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
This federal contract award is for the delivery of Advair HFA 230-21 mcg inhaler products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is a firm fixed price delivery order with a potential value of $9,292.96 and a completion date of February 21, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB24FVZN0
    Delivery Order

The federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers, with a ceiling value of $1,573.29. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. This contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation. The period of performance runs from the award date of April 29, 2024 to the ultimate completion date of April 30, 2024.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

Generated 7/29/24, 9:11 AM